Functional somatic syndromes: One or many?

Lancet

Volumn 354, Issue 9182, 1999, Pages 936-939

  Wessely, S ^a   Nimnuan, C ^a   Sharpe, M ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC FATIGUE SYNDROME; EMOTIONAL STRESS; FEMALE; FIBROMYALGIA; HUMAN; IRRITABLE COLON; MALE; NEUROSIS; PRIORITY JOURNAL; SEX DIFFERENCE; SHORT SURVEY; SOMATIZATION; SYMPTOM;

EID: 0033547013     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)08320-2     Document Type: Review

References (29)

1. Sharpe M., Mayou R., Bass C. Concepts, theories and terminology. Mayou R., Bass C., Sharpe M. Treatment of functional somatic symptoms. 1995;3-16 Oxford University Press, Oxford.
2. Peveler R., Kilkenny L., Kinmonth A. Medically unexplained physical symptoms in primary care: a comparison of self-report screening questionnaires and clinical opinion. J Psychosom Res. 42:1997;245-253.
3. Van Hemert A., Hengeveld M., Bolk J., Rooijmans H., Vanderbroucke J. Psychological disorders in relation to medical illness among patients of a general medical outpatient clinic. Psychol Med. 23:1993;167-173.
4. Hamilton J., Campos R., Creed F. Anxiety, depression and management of medically unexplained symptoms in medical clinics. J R Coll Physicians. 30:1996;18-21.
5. Fink P. The use of hospitalizations by persistent somatizing patients. Psychol Med. 22:1992;173-180.
6. Walker E.A., Roy Byrne P.P., Katon W.J., Li L., Amos D., Jiranek G. Psychiatric illness and irritable bowel syndrome: a comparison with inflammatory bowel disease. Am J Psych. 147:1990;1656-1661.
7. Komaroff A., Fagiolo L., Doolittle T.et al. Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups. Am J Med. 101:1996;281-290.
8. Potts S., Bass C. Psychological morbidity in patients with chest pain and normal or near-normal coronary arteries: a long-term follow-up study. Psychol Med. 24:1995;339-347.
9. Kroenke K., Price R. Symptoms in the community: prevalence, classification and psychiatric comorbidity. Arch Intern Med. 153:1993;2474-2480.
10. Melville D. Descriptive clinical research and medically unexplained physical symptoms. J Psychosom Res. 31:1987;359-365.
11. Cloninger C., Martin R., Guze S., Clayton P. A prospective follow-up and family study of somatization in men and women. Am J Psych. 143:1986;873-878.
12. Russo J., Katon W., Sullivan M., Clark M., Buckwald D. Severity of somatization and its relationship to psychiatric disorders and personality. Psychosomatics. 35:1994;546-556.
13. Simon G., VonKorff M. Somatization and psychiatric disorder in the NIMH Epidemiologic Catchment Area Study. Am J Psych. 148:1991;1494-1500.
14. Kroenke K., Spitzer R., Williams J. Physical symptoms in primary care: predictors of psychiatric disorders and functional impairment. Arch Fam Med. 3:1994;774-779.
15. Wessely S., Chalder T., Hisch S., Wallace P., Wright D. Psychological symptoms, somatic symptoms and psychiatric disorders in chronic fatigue and chronic fatigue syndrome: a prospective study in primary care. Am J Psych. 153:1996;1050-1059.
16. Sharpe M., Bass C. Pathophysiological mechamisms in somatisation. Int Rev Psych. 4:1992;81-97.
17. White P., Moorey S. Psychosomatic illnesses are not "all in the mind" J Psychosom Res. 42:1997;329-332.
18. Sharpe M., Mayou R., Seagroatt V.et al. Why do doctors find some patients difficult to help? Quart J Med. 87:1994;183-187.
19. Cleare A., Harp E., Malhi G., Wessely S., O'Keane V., Miell J. A randomized, double-blind, placebo-controlled crossover trial of low-dose hydrocortisone in chronic fatigue syndrome. Lancet. 353:1999;455-458.
20. Martin L., Nutting A., Macintosh B., Edworthy S., Butterwick D., Cook K. An exercise program in the treatment of fibromyalgia. J Rheumatol. 23:1996;1050-1053.
21. Scordo K. Effects of aerobic exercise training on symptomatic women with mitral valve prolapse. Am J Cardiol. 67:1991;863-868.
22. Van Outryve M., Mayeur S., Rosillon D., Hendrickx B. A double blind crossover comparison study of the safety and efficacy of mebeverine with mebeverine sustained release in the treatment of irritable bowel syndrome. J Clin Pharmacol Therap. 20:1995;277-282.
23. Robbins J., Kirmayer L., Hemami S. Latent variable models of functional somatic distress. J Nerv Ment Dis. 185:1997;606-615.
24. Deary I. A taxonomy of medically unexplained symptoms. J Psychosom Res. 47:1999;51-59.
25. Mayou R., Bass C., Sharpe M. The treatment of functional somatic symptoms. 1995;Oxford University Press, Oxford.
26. Ryle, J. Visceral neuroses. Lancet 1939; ii: 297-301, 353-59, 407-12.
27. Halliday J. Concept of a psychosomatic affection. Lancet. ii:1943;692-696.
28. Halliday J. The significance of "the concept of a psychosomatic affection": comments from contributors relative to the psychosomatic concept. Psychosom Med. 7:1945;240-245.
29. Kissen D. The significance of syndrome shift and late syndrome association in psychosomatic medicine. J Nerve Ment Dis. 136:1963;34-42.